UBS Group’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $804K | Buy |
|
|||||
|
2025
Q2 | $150K | Sell |
|
|||||
|
2025
Q1 | $226K | Sell |
|
|||||
|
2024
Q4 | $557K | Buy |
|
|||||
|
2024
Q3 | $109K | Sell |
|
|||||
|
2024
Q2 | $438K | Sell |
|
|||||
|
2024
Q1 | $4.22M | Buy |
|
|||||
|
2023
Q4 | $1.67K | Sell |
|
|||||
|
2023
Q3 | $1.34M | Sell |
|
|||||
|
2023
Q2 | $2.53M | Buy |
|
|||||
|
2023
Q1 | $1.43M | Sell |
|
|||||
|
2022
Q4 | $3.12M | Buy |
|
|||||
|
2022
Q3 | $542K | Sell |
|
|||||
|
2022
Q2 | $839K | Sell |
|
|||||
|
2022
Q1 | $3.43M | Buy |
|
|||||
|
2021
Q4 | $2.98M | Buy |
|
|||||
|
2021
Q3 | $18K | Buy |
|
|||||
|
2021
Q2 | $14K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $9K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $12K | Buy |
|